| Name: | KESIN PHARMA CORPORATION |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 12 Feb 2021 (4 years ago) |
| Entity Number: | 5940452 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | Arizona |
| Address: | 28 LIBERTY STREET, New york, NY, United States, 10005 |
| Principal Address: | 3874 Tampa Road, STE 103, Oldsmar, FL, United States, 34677 |
| Name | Role | Address |
|---|---|---|
| KESIN PHARMA CORPORATION | DOS Process Agent | 28 LIBERTY STREET, New york, NY, United States, 10005 |
| Name | Role | Address |
|---|---|---|
| ADAM SCHOENBAUM | Chief Executive Officer | 3874 TAMPA ROAD, STE 103, OLDSMAR, FL, United States, 34677 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY STREET, NEW YORK, NY, 10005 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2025-02-03 | 2025-02-03 | Address | 3874 TAMPA ROAD, STE 103, OLDSMAR, FL, 34677, USA (Type of address: Chief Executive Officer) |
| 2025-02-03 | 2025-02-03 | Address | 1907 E UNIVERSITY DRIVE, STE 101, PHOENIX, AZ, 85034, USA (Type of address: Chief Executive Officer) |
| 2021-02-12 | 2025-02-03 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Registered Agent) |
| 2021-02-12 | 2025-02-03 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 250203005610 | 2025-02-03 | BIENNIAL STATEMENT | 2025-02-03 |
| 230201000542 | 2023-02-01 | BIENNIAL STATEMENT | 2023-02-01 |
| 210212000114 | 2021-02-12 | APPLICATION OF AUTHORITY | 2021-02-12 |
| Docket Number | Nature of Suit | Filing Date | Disposition | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2407516 | Overpayments & Enforcement of Judgments | 2024-10-28 | voluntarily | |||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| Name | KESIN PHARMA CORPORATION |
| Role | Plaintiff |
| Name | SAPTALIS PHARMACEUTICALS, LLC |
| Role | Defendant |
Date of last update: 22 Mar 2025
Sources: New York Secretary of State
